Rescued from a trash bin in Northern Virginia, Olive, a pit bull terrier, is now happy in her Verona home. She is in the ...
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...
Citing preliminary unaudited results on Tuesday, Verona Pharma (NASDAQ:VRNA) reported ~$36M and $42M in net product sales for Q4 and the full year 2024, respectively, thanks to its newly launched lung ...